Showing results (441-450 of 566) with videos related to
Sort By:
Pageof 57
Blood|March 1, 1996
A pilot study of high-dose interleukin-3 treatment of relapsed follicular small cleaved-cell lymphoma: hematologic, immunologic, and clinical resultsA Younes, A Sarris, U Consoli, et al.Leukemia|December 1, 2009
Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axisK Kojima, M Konopleva, T Tsao, et al.Blood|April 21, 2001
Autocrine cell suicide in a Burkitt lymphoma cell line (Daudi) induced by interferon alpha: involvement of tumor necrosis factor as ligand for the CD95 receptorH Gisslinger, R Kurzrock, B Gisslinger, et al.Leukemia|December 19, 2012
HDAC inhibition by SNDX-275 (Entinostat) restores expression of silenced leukemia-associated transcription factors Nur77 and Nor1 and of key pro-apoptotic proteins in AMLL Zhou, V R Ruvolo, T McQueen, et al.Cancer Gene Therapy|October 31, 2009
Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cellsJ L Dembinski, E L Spaeth, J Fueyo, et al.British Journal of Haematology|November 14, 1997
Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow-up of patients in clinical remissionH Engel, A Goodacre, A Keyhani, et al.Blood|July 15, 1996
The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell linesU Consoli, W Priebe, Y H Ling, et al.British Journal of Haematology|January 29, 2000
Clinical and laboratory evaluation of all-trans retinoic acid modulation of chemotherapy in patients with acute myelogenous leukaemiaK Seiter, E J Feldman, H Dorota Halicka, et al.International Journal of Cancer|March 28, 1997
Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposideR Perez-Soler, N Neamati, Y Zou, et al.Leukemia|January 23, 2004
PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylationT Jiffar, S Kurinna, G Suck, et al.Pageof 57